Nestlé Health Science Licenses Rights for LT-02 as Ulcerative Colitis Therapy
News
Nestlé Health Science recently announced that it has entered into a license partnership with Lipid Therapeutics, a biopharmaceutical company focused on the development and commercialization of phospholipids, for global exclusive ... Read more